Real-World treatment outcomes for advanced NSCLC in Greece
Year: 2023
Type: conference-abstract
Source: European Respiratory Journal
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: advanced non-small cell lung cancer, PD-1/PD-L1 inhibitors, pembrolizumab, real-world treatment outcomes, first-line therapy, progression-free survival, overall survival, PD-L1 testing, platinum-based chemotherapy, anti-VEGF therapy, tyrosine kinase inhibitors, ALK-positive non-small cell lung cancer
Open Access status: closed
OpenAlex ID: W4387981995
